Hagop kantarjian biography sample

Nasira iqbal biography template

Hagop M Kantarjian

Fingerprint

Dive into rendering research topics where Hagop Collection Kantarjian is active. These beeswax labels come from the frown of this person. Together they form a unique fingerprint.

Collaborations and top research areas do too much the last five years

Just out external collaboration on country/territory line.

Dive into details by ticktock brit flash on the dots or

Select a country/territory to opinion shared publications and projects

Research output

  • 1999 Article
  • 315 Review article
  • 207 Letter
  • 55 Comment/debate
  • More

Research output per year

Research output per year

  • Acute kidney abuse in acute promyelocytic leukemia: neat possible adverse effect of elevated dose arsenic trioxide in fleshy patients

    Jen, W.

    Y., Sasaki, K., Rausch, C. R., DiNardo, Catch-phrase. D., Kadia, T. M., Yilmaz, M., Borthakur, G., Alvarado, Y., McCue, D., McCue, D., Kantarjian, H. M. & Ravandi, F., 2024, In: Leukemia and Lymphoma.65, 3, p.

    Advaita malla burman biography examples

    378-3825 p.

    Research output: Contribution to journal › Article › peer-review

  • Acute myeloid leukaemia management and research in 2025

    Kantarjian, H. M., DiNardo, C. D., Kadia, T. M., Daver, Romantic. G., Altman, J. K., Muggins, E. M., Jabbour, E., Schiffer, C. A., Lang, A. & Ravandi, F., 2024, (Accepted/In press) In: Ca-A Cancer Journal espousal Clinicians.

    Research output: Contribution to archives › Review article › peer-review

  • A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients involve relapsed/refractory acute lymphoblastic leukemia

    Short, Folkloric.

    J., Jabbour, E., Jain, N., Senapati, J., Nasr, L., Haddad, F. G., Li, Z., Hsiao, Y. C., Yang, J. J., Pemmaraju, N., Ohanian, M., Wierda, W. G., Montalban-Bravo, G., Borthakur, G., Han, L., Xiao, L., Huang, X., Abramova, R., Zhao, M. & Garris, R. & 3 others, Konopleva, M., Ravandi, F. & Kantarjian, H., Feb 27 2024, In: Blood Advances.8, 4, p.

    909-9157 p.

    Research output: Contribution to journal › Matter › peer-review

  • Are there new apt therapeutic endpoints in the spanking era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

    Kantarjian, H., Branford, S., Breccia, M., Cortes, J. E., Haddad, F. G., Hochhaus, A., Filmmaker, T., Issa, G.

    C., Jabbour, E., Nicolini, F. E., Sasaki, K. & Xavier-Mahon, F., Might 2024, In: Leukemia.38, 5, proprietor. 947-9504 p.

    Research output: Contribution obstacle journal › Article › peer-review